Gambaran Pengobatan Pasien Terkonfirmasi Covid-19 yang Melakukan Isolasi Mandiri di Rumah

Reni Ariastuti, Atik Aryani, Rita Septiana

Abstract


Covid-19 (Coronavirus Disease -19) pandemic is still a health problem for Indonesia and even the world. The limitations of health facilities such as hospitals in treating Covid-19 patients require Covid-19 patients with mild to moderate symptoms to self-quarantine/isolate at home. This study was conducted to see the description of treatment for confirmed Covid-19 patients who are self-isolating at home. The descriptive method was used in this study by purposive random sampling of confirmed Covid-19 patients who were self-isolating at home by filling out a questionnaire from a google form. The previous questionnaire had gone through the content validity stage by professional health workers, pharmacists, nurses and doctors. The data obtained were processed and analyzed in a qualitative descriptive manner based on the guidelines for the treatment of patients confirmed positive for COVID-19 from the Ministry of Health of the Republic of Indonesia and WHO (World Health Organization). This study displays data that there are 52 Covid-19 respondents who self-isolate at home, 75% receive doctor's prescription services and 25% without a doctor's prescription. The use of drugs on a doctor's prescription is in accordance with the Covid-19 therapeutic management from the Ministry of Health with the therapy given in the form of azithromycin, oseltamivir, vitamin C, vitamin D, and symptomatic therapy. While the use of drugs without a doctor's prescription, 8% use hard drugs without a doctor's prescription, while 92% of respondents use over-the-counter and limited-free drugs to treat symptoms and complaints. The treatment of Covid-19 patients who are self-isolating at home, whether with a doctor's prescription or not, is in accordance with the Covid-19 management guidelines from the Ministry of Health.


Keywords


Medicine; Covid-19; Self-isolation

Full Text:

PDF

References


Anonim, 2020, Pedoman Penggunaan Herbal dan Suplemen Kesehatan dalam Menghadapi Covid-19 di Indonesia. Jakarta: Badan Pengawas Obat dan Makanan (I).

Azizah, K.N. 2020, Viral Daftar Obat untuk Pasien COVID-19, Ini Pesan Dokter Paru. Available at: https://health.detik.com/berita-detikhealth/d-5312888/viral-daftar-obat-untuk-pasien-covid-19-ini-pesan-dokter-paru.

Bimantara, D.E. 2020, Peran Vitamin C dalam Pengobatan COVID-19, Majority, 9(1), 4.

Bimo Aria, F. 2020, BPOM Rilis 6 Tumbuhan Obat Herbal Untuk Cegah Covid-19, Apa Saja itu? Available at: https://www.suara.com/health/2020/05/27/072500/bpom-rilis-6-tumbuhan-obat-herbal-untuk-cegah-covid-19-apa-saja-itu?page=all.

Biro Komunikasi, B. 2021, Pemerintah Gandeng 11 Platform Telemedicine Sediakan Layanan Konsultasi Kesehatan dan Pengiriman Obat Gratis bagi Pasien Isoman. Kementerian Koordinator Bidang Kemaritiman dan Investasi. Available at: https://maritim.go.id/pemerintah-gandeng-11-platform-telemedicine-sediakan-layanan-konsultasi/.

Burhan, E. et al. 2020, Pedoman Tatalaksana Covid-19 Edisi 3.

Damo, N.Y. et al. 2021, Diagnostik Coronavirus Disease 2019 (COVID-19) dengan Pemeriksaan Laboratorium Mikrobiologi Klinik, Jurnal e-Biomedik, 9(1). doi:10.35790/ebm.v9i1.31899.

Fathoni, M.N. 2020, Edukasi Tentang Covid-19 Serta Pemanfaatan Tanamaan Herbal Pada Pedagang Jamu Keliling Di Desa Tanjungsari, 4(2), 7.

Hendryadi, H. 2017, Validitas Isi: Tahap Awal Pengembangan Kuesioner, Jurnal Riset Manajemen dan Bisnis (JRMB) Fakultas Ekonomi UNIAT, 2(2), 169–178. doi:10.36226/jrmb.v2i2.47.

Levani, Y., Prastya, A.D. and Mawaddatunnadila, S. 2021, Coronavirus Disease 2019 (COVID-19): Patogenesis, Manifestasi Klinis dan Pilihan Terapi, 17(1), 14.

Makmun, A. and Rusli, F.I.P. 2020, Pengaruh Vitamin C Terhadap Sistem Imun Tubuh Untuk Mencegah Dan Terapi Covid-19, Molucca Medica, 60–64. doi:10.30598/molmed.2020.v13.i2.60.

Purwati et al. 2021, An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia’, PLOS ONE. Edited by M. Sanyal, 16(6), p. e0252302. doi:10.1371/journal.pone.0252302.

Sadikin, B.G. 2021, Selamat datang di Layanan Telemedisin Isoman COVID-19. Available at: https://isoman.kemkes.go.id/index.html.

Sahara, W. 2021, Sebaran Varian Alpha, Beta, Delta, Eta, Kappa dan Iota di Indonesia Data 6 Juli 2021, July. Available at: https://nasional.kompas.com/read/2021/07/06/14405061/sebaran-varian-alpha-beta-delta-eta-kappa-dan-iota-di-indonesia-data-6-juli?page=all.

Satuan Tugas Penanganan Covid-19, 2021, Perkembangan Kasus Terkonfirmasi Positif Covid-19 Per-Hari, Peta Sebaran Covid-19. Available at: https://covid19.go.id/peta-sebaran-covid19.

Susilo, A. et al. 2020, Coronavirus Disease 2019: Tinjauan Literatur Terkini, Jurnal Penyakit Dalam Indonesia, 7(1), 45. doi:10.7454/jpdi.v7i1.415




DOI: http://dx.doi.org/10.33087/jiubj.v22i2.2348

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

ADRESS JOURNAL

JURNAL ILMIAH UNIVERSITAS BATANGHARI JAMBI (JIUBJ)
Published by Lembaga Penelitian dan Pengabdian kepada Masyarakat
Adress: Jl.Slamet Ryadi, Broni-Jambi, Kec.Telanaipura, Kodepos: 36122, email: jiubj.unbari@gmail.com, Phone: 0741-670700

Creative Commons License This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.